OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-03-31-accounts

Mr
I C Martin
Chair
Dr D G Mason Honorary Treasurer
Mrs J Barber
Dr P J Greaves Honorary Treasurer (elect)
Professor TJ Hendra
Professor Sir 8 Keogh
Professor
N Kumar
Appointed 4'"January 2022
Dr 5 Lishman
CBE
Professor
M Sani
Appointed 4'"January 2022
The principal address ofthe charity and the registered office ofthe company isthe offices of NCEPOD at Abbey House, 74-
76StJohn Street, London, EC1M 4DZ.

Association ofAnaesthetists Royal College ofOphthalmologists
Dr W Fawcett Vacancy
Association ofSurgeons of Great Britain and Ireland Royal College of Paediatrics
and Child Health
Mr M Lansdown Dr I Doughty
Royal College of Emergency Medicine Royal College of Physicians of London
Dr A Boyle Dr A Gibson, Dr M Kumwenda
and Dr H Skene
Faculty of Dental Surgery Royal College of Physicians
and Surgeons of Glasgow
Mr J Dhanda Dr M McKirdy —moved to observer status 4 Nov 21
Faculty of Intensive
Care Medicine
Royal College of Physicians of Edinburgh
Dr J Butler Dr J MacLeod —moved to observer status 4 Nov 21
Lay Representatives Royal College of Psychiatrists
Vacancy Vacancy
Royal College of Anaesthetists Royal College of Radiologists
Dr C Carey and Dr K Ramachandaran Prof R McWilliams
Royal College of General Practitioners Royal College of Pathologists
Vacancy Dr L Igali
Royal College of Nursing Royal College ofSurgeons of Edinburgh
Dr N Ashby Miss A Paisley —moved to observer status 4 Nov 21
Royal College ofObstetricians and Gynaecologists Royal College ofSurgeons of England
DrT Hillard Miss SVig
Twelve consultants had been on secondment to NCEPOD as Clinical Co-ordinators NCEPOD as Clinical Co-ordinators between 1April 2021 and 31 March
2022, committing to between
one and two sessions
per week.
Dr M Docherty Liaison Psychiatry
Dr A Goodwin Anaesthesia
and Critical Care
Dr M Juniper Respiratory
Medicine
Dr K Malbon Paediatrics
Dr SMcPherson Radiology
Dr D McWilliams Physiotherapy
—appointed
in March 22
Dr A Michalski Paediatric
Oncology
Mr M Sinclair General Surgery
Dr V Srivastava Acute Medicine
Dr ATavare General Practice
Dr K Wilkinson Paediatric Anaesthesia —left in October 21
Mr J Abercrombie Surgery

Area ofstudy: Milestone reached:
Physical healthcare in mental health hospitals Report is due for release 14/4/22
Epilepsy Data being reviewed
Crohn's disease Cases being reviewed
Community
acquired
pneumonia Data collection just starting
Transition
between
child and adult healthcare Cases being reviewed
Endometriosis Study being developed
End of life care Study being developed
Testicular torsion Study being developed
Natural
deaths
in prison
Data collection underway
Juvenile arthritis Study being developed
Blood sodium Study being developed
ICU rehabilitation Study being developed

Year ending 31March 2 022
Total Total
Notes 2022 2021
E E
INCOME FROM:
Donations 132,900 12,000
Charitable
activities
1,243,871 1,154,353
Investments 6,741 10,303
TOTAL INCOME 1,383,512 1,176,656
EXPENDITURE ON:
Charitable
activities
1,216,165 972,248
TOTAL EXPENDITURE 1,216,165 972,248
Net gain on investments 11,311 34,820
NET INCOME 178,658 239,228
NET MOVEMENT IN FUNDS 178,658 239,228
RECONCILIATION
OF FUNDS
Fund balances brought forward
at 1April 2021 1,515,571 1,276,343
FUND BALANCES CARRIED FORWARD
AT31MARCH 2021 1,694,229 1,515,571

Notes 2022 2021
f f
FIXEDASSETS
Tangible assets 838 3,292
Investments 223,849 212,538
224,687 215,830
CURRENT ASSETS
Debtors 376,339 355,757
Cash at bank and in hand 1,264,869 1,091,609
1,641,208 1,447,366
LIABILITIES
Creditors: Amounts falling due within one year 10 (171,666) (147,625)
NET CURRENT ASSETS 1,469,542 1,299,741
TOTAL ASSETS LESS CURRENT LIABILITIES
& NET ASSETS 1,694,229 1,515,571
THE FUNDS OF THE CHARITY
Unrestricted
income
funds
General
Fund
1,664,229 1,495,571
Designated
Premises
Fund 30,000 20,000
TOTAL CHARITY FUNDS 1,694,229 1,515,571

REGISTERED COMPANY N O. 030 19382
CASH FLOWS
Year ending 31March 2022
Notes 2022 2021
f E
Cash flows from operating activities
Net cash provided
by operating
activities 13 167,023 338,206
Cash flows from investing activities
Interest from investments 6,741 10,303
Purchase oftangible fixed assets (504) (1,737)
Receipts from sale ofinvestments 174,875
Purchase ofinvestments (200,637)
Net cash (outflow) inflow from investing activities 6,237 (17,196)
Increase (decrease) in cash for the year 173,260 321,011
Cash brought forward 1,091,609 770,598
Cash carried forward
1,264,869 1,091,609

NATIONAL
CONFIDENTIAL
ENQUIRY INTO PATIENT OUTCOME AND DEATH
REGISTERED COMPANY NO. 03019382
ACCOUNTING
POLICIES
Year ending 31March 2022

O THE FINANCIAL STATE
ng 31March 2022
MENTS
Total Total
2022 2021
f f
DONATIONS:
Donated services 132,900 12,000
132,900 12,000
INCOME FROM CHARITABLE ACTIVITIES- DESIGNING AND RUNNING CONFIDENTIAL SURVEY
Healthcare
Quality Improvement
1,207,221 1,091,234
Partnership
(HQIP)
Private hospitals 30,650 49,800
Conference,
exhibition
and other
income sources 6,000 13,319
1,243,871 1,154,353
INVESTMENT INCOME
Dividends 6,079 8,161
Bank interest receivable on
short term cash deposits 662 2,142
6,741 10,303

Total Total
2022 2021
f f
Support costs (note 5) 241,369 244,142
Direct staff costs (note 6) 574,354 515,358
Other direct expenditure:
Staff healthcare,
training,
and recruitment
2.337 1,441
Clinical co-ordinators
secondments
217,746 177,881
Clinical reviewers
(donated services)
132,900 12,000
Clinical co-ordinators, reviewers, and
staff expenses 14,757 6,508
Consultancy 13,235 2,009
Temporary
staff costs
4,696
Conference, exhibition, and meetings
expenses 371 (2,325)
Operating
lease rentals:
Plant and machinery 7,247 5,666
Other printing
and report production
costs 4,782 5,536
Postage and distribution 2,371 4,032
1,216,165 972,248
O THE FINANCIAL STATEMENT
ng 31March 2022
S
Support Governance Total Total
costs costs 2022 2021
f E E E
SUPPORT AND GOVERNANCE COSTS
Staff costs (note 6) 746 746 691
Other expenditure:
Operating
lease rentals:
Land and buildings 133,644 133,644 136,747
Other premises costs 22,521 22,521 15,854
Auditors'
remuneration:
Audit fees 8,100 8,100 10,288
Bookkeeping
and payroll costs
9,352 14 9,366 11,086
Public relations 859 1 860 454
Computer
expenses
Insurance
21,919
20,562
32
30
21,951
20,592
31,127
17,635
Sundry expenses
Telephone
Office costs
6,054
4,741
8,933
11
7
14
6,065
4,748
8,947
4,247
4,536
5,400
Steering Group expenses 680 1 681
Trustee expenses
Depreciation
—owned assets
2,954 2,958 5,934
Bank charges 190 190 143
232,410 8,959 241,369 244,142

PRIOR YEAR COIVIPARATIVE
Support Governance Total Total
costs costs 2021 2020
f E f f
SUPPORT AND GOVERNANCE COSTS
Staff costs (note 6) 691 691 1,490
Other expenditure:
Operating
lease rentals:
Land and buildings 136,747 136,747 145,620
Other premises costs 15,854 15,854 20,810
Auditors'
remuneration:
Audit fees 10,288 10,288 10,000
Bookkeeping
and payroll costs
10,920 166 11,086 26,217
Public relations 447 7 454
Computer
expenses
30,0660 467 31,127 30,111
Insurance 17,370 265 17,635 17,077
Sundry expenses 4,183 64 4,247 13,063
Telephone 4,468 68 4,536 2,832
Office costs 5,319 81 5,400 10,877
Steering Group 3,837
Trustee expenses 3,042
Depreciation
-owned assets
5,849 85 5,934 5,640
Bank charges 143 143 88
231,960 12,181 244,142 290,704
2022 2021
STAFF COSTS
No. No.
The average monthly number ofpersons employed by
NCEPOD during the year (excluding Trustees) was:
Designing
and running
ofconfidential surveys 14 14
Staff costs for the above persons:
Wages and salaries
Social security costs
480,526
47,322
434,049
38,975
Pension costs 47,252 43,025
575,100 516,049
Staff costs are allocated
in the financial statements,
as follows:
Designing
and running
Governance
costs
of confidential surveys —unrestricted 574,354
746
515,358
691
575,100 516,049

Computer Fixtures &
equipment
f
fittings
f
TOTAL
f
Cost:
1April 2021 30,351 15,033 45,384
Additions 504 504
Disposals
31March 2022 30,855 15,033 45,888
Depreciation:
1April 2021 27,208 14,884 42,092
Charge
in the year
2,809 149 5,934
Depreciation
on disposal
31March 2022 30,017 15,033 42,092
Net book value:
31March 2022 838 838
31March 2021 3,143 149 3,292
2022 2021
INVESTMENTS
Listed investments:
Opening
balance at 1
April 212,538 151,957
Additions at cost 200,637
(inc cash account movement)
Disposals (174,875)
Realised gains/losses in investments 22,918
Unrealised
gains/losses
on investments
11,311 11,902
Market value at 31March 223,849 212,538
2022 2021
Analysis ofinvestment holdings
QC Global income and Growth Fund 223,849 212,538
Market value at31March 223,849 212,538
DEBTORS
Amounts
falling due within one
year:
Trade debtors 304,871 287,351
Other debtors 24,643 25,645
Prepayments 46,825 42,761
376,339 355,757
10. CREDITORS
Amounts
falling due within one
year:
Trade creditors 7,752 35,268
Accruals and deferred income 163,914 112,357
171,666 147,625
Deferred income
Deferred income at 1 April 2021 88,000
Resources deferred
during the
year 22,000 88,000
Amounts
released from previous years
110,000 88,000

1April Income Expenditure Gain on 31March
2021 Investment 2022
f E f
Unrestricted income funds:
General Fund 1,495,571 1,383,512 (1,216,165) 11,311 1,664,229
Designated Premises 20,000 30,000
Fund
1,515,571 1,383,512 (1,216,165) 11,311 1,694,229
1April Income Expenditure Gain on 31March
2020 Investment 2021
E E f
Unrestricted income funds:
General Fund 1,256,343 1,176,656 (972,247) 34,820 1,495,571
Designated Premises 20,000 20,000
Fund
1,276,343 1,176,656 (972,247) 34,820 1,515,571

Fixed asset Tangible fixed Net current Total
investments assets assets
Unrestricted income funds:
General
Fund
223,849 838 1,449,542 1,664,229
Designated Premises Fund 20,000 30,000
NET ASSETS AT31MARCH 2022 223,849 838 1,469,542 1,694,229
Fixed asset Tangible fixed Net current Total
investments assets assets
Unrestricted income funds:
General
Fund
212,538 3,292 1,279,741 1,495,571
Designated Premises Fund 20,000 20,000
NET ASSETS AT31MARCH 2021 212,538 3,292 1,299,741 1,515,571

2022 2021
E E
Net income for the year 178,659 239,228
Depreciation
(note
7) 2,959 5,934
(Gains) on investments (11,311) (34,820)
Interest from investment (6,741) (10,303)
Decrease (Increase) in debtors (20,582) 5,639
(Decrease) increase in creditors 24,039 132,528
Net cash from operating activities 167,023 338,206

At 31March 2022, NCEPOD
operating
leases:
had future
minimu
m
lease paymen
ts
under non-cancellabl
e
2022 2021
Land & Building Equipment Land Ik Building Equipment
Within 1year E69,323 E5,606 E142,000 E5,606
Within 2-5years E22,424 E71,000 E1,402
Total f69,323 E28,030 E213,000 E7,008
NET DEBT RECONCILIATION
At 1 April 2021 Cash flows
At 31March 2022
E
Cash at bank and in hand 1,091,609 173,260 1,264,869
Debt
Total 1,091,609 173,260 1,264,869
ANALYSIS OF CASH AND CASH EQUIVALENTS
2022 2021
f E
Cash in hand 1,264,869 1,091,609
Total cash and cash equivalents 1,264,869 1,091,609